Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
about
Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementIdiopathic inflammatory myopathiesDeciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.Idiopathic inflammatory myopathies.A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathyRituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case seriesAnti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statinAnti-signal recognition particle autoantibodies: marker of a necrotising myopathy.The heterogeneity of juvenile myositisThe clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.Clinical and pathological roles of Ro/SSA autoantibody system.Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in JapanMyositis-related interstitial lung disease and antisynthetase syndromeAssessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositisThe myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.Polymyositis anti-SRP antibodies and pregnancy about 2 cases.Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Clinical implication of autoantibodies in patients with systemic rheumatic diseases.Cutting edge issues in polymyositis.Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.PET/CT imaging in inflammatory myopathies.Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.Myositis autoantibodies.Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.Autoantibodies in polymyositis and dermatomyositis.Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.Novel antibody associations in immune-mediated necrotising myopathy without inflammation.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.
P2860
Q26744705-AF038973-E3F7-45B6-837B-D193E330F9F5Q27025125-2D5F749F-0EE8-434E-B9F1-6B1FC16E4823Q33717793-5E65AB62-5E01-4D9C-8759-5440F70E1421Q33844947-AC338211-64DD-4223-8C65-B4DCEBECA567Q33924451-16C5C8E5-10D2-4E83-B7ED-7D521037C163Q34520109-D1D56118-03AB-4590-A890-6257782FD92BQ34644962-4C3AD5F6-5E84-4784-A3E9-E6B1DB165EB5Q34896166-0EE20523-FDBF-4B5A-B607-040E461C1C89Q35021812-DF0577CF-1E49-4336-BC20-70EA9B664425Q35163067-68A8DD71-20BF-4B9A-A72E-339D8FD0FC97Q35638565-E9A54FE0-A9CD-4546-BE41-CCF5BA0AC7DEQ35748264-42B677B8-7B75-434F-BFA5-2277B85DFD87Q36086954-092A3AAE-009A-4153-898C-2DCB7ADFA410Q36283423-C272BEE3-C56A-4ED5-BAAE-0EAB4C1905D0Q36469094-8B34F426-AB1E-420A-8512-757C9AD6721FQ36559044-B675BAA3-024A-4ABD-B190-EAF6F08D053EQ36913833-2703070D-B812-4C59-A289-6144A52763C9Q36925590-C2E84CED-1D13-42D3-9CDF-F83E436C2BCFQ37023594-35C8AAFB-6257-408A-A274-D9AA07B28206Q37040711-6D635CBF-B6BA-44AB-AF1C-70AC25C8FC7FQ37280014-F484415D-50D7-41DC-BF4A-C0D7CAF36F85Q37345669-35433EDA-D4C2-435E-8291-83DA1D8C2D3AQ37354591-89A69239-2FF8-4F59-926E-68A94BE7E4AEQ37480302-3B2B18F5-6D3A-43D7-A94A-8421F3F51B82Q37691061-D5A03921-6642-4C64-B6A4-C70436F68418Q37704799-0371AD02-853A-429C-A0C1-49B7F06195E2Q37754648-DFCF0E3B-FECF-4849-B5C7-7C4642AE9239Q37824617-DAE0F033-8EC3-4AE9-9236-95FC06A4F735Q37886653-609A3575-6B57-461B-91E8-C2A63B3AABF4Q37896133-67A4F5CC-86E5-4D4B-B4FD-4208C27DAAC3Q37937430-93FD3742-3D0C-42F0-80D4-10680D1DDC4EQ38041385-89B6B770-8C39-4EB8-9695-C11160009E76Q38044467-21B97182-5E50-432A-ABD0-08AAF482EEB7Q38099556-C8E3D490-0DA2-4E17-9DCE-6B8675A30695Q38124282-85B3EEAC-D43F-4B65-B2DB-29CB05C99083Q38264055-7A4B4458-914C-4153-AFB7-344A56A277ACQ38596370-C8A5A990-36F2-4EE1-814D-214664D19839Q38619882-BD904485-F011-4123-8D07-7FAC8B35612FQ38646384-A62609AB-CAF8-4AEA-885F-FB134BD8A837Q38654184-1859DCFC-6D6B-493E-9C39-60B149E2A471
P2860
Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@ast
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@en
type
label
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@ast
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@en
prefLabel
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@ast
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@en
P2093
P356
P1476
Anti-signal recognition partic ...... opathic inflammatory myopathy.
@en
P2093
Chester V Oddis
David Lacomis
Mary Lucas
Noreen Fertig
P304
P356
10.1002/ART.11484
P577
2004-01-01T00:00:00Z